MARS: Magnetic Resonance Study: A Novel Assessment of Placental Function

Status Completed

Clinical Trial Summary

The objective of this study is to evaluate functional MRI as a tool to study placental transfer of oxygen and nutrients during the third trimester of pregnancy in obese women, women with pregestational diabetes and healthy low risk women without these conditions (controls). The investigators hypothesize that altered placental function, including diminished placental oxygenation and enhanced placental transport of lipids and metabolites will be seen in obese and pregestational diabetics as compared to controls.

Clinical Trial Description

In this study, we propose to utilize two novel and innovative non-invasive tools to measure placental oxygenation and lipid and nutrient transport in vivo in women who are obese (OB), have pregestational diabetes (DM) or have neither (controls). To evaluate differences in placental oxygenation, we propose to use Blood Oxygen Level Depending (BOLD) imaging, a method of functional magnetic resonance imaging, to measure tissue oxygenation in the placenta during the third trimester of pregnancy. To evaluate placental lipid and nutrient content, we propose to utilize Magnetic Resonance Spectroscopy (MRS), a novel and powerful tool to compare lipid and nutrient transport across the placenta among OB, DM and controls. To confirm in vivo BOLD and MRS findings, we will extensively evaluate the placental lipid content and lipid transport capability. Fatty acid transport protein-4 (FATP-4), one of 6 FATP proteins, is important for placental lipid accumulation, especially LC-PUFA21-24. Docosahexaenoic acid (DHA) is a crucial LC-PUFA for neurogenesis in early development18. Major facilitator super family domain containing MFSD2a is a lysophospholipid transporter required for DHA uptake in the brain and has been linked to placental DHA transfer. Lipid content of the placenta can be assessed by visualizing lipid droplets via perilipin 2, the most abundant structural protein on the surface of lipid droplets of adipocytes. We hypothesize that altered placental function including diminished placental oxygenation and abnormal placental transport of lipids and other metabolites will be seen in OB and DM women as compared to controls. We further hypothesize that ex vivo placental pathologic, histologic and immunohistochemistry characteristics will be associated with in vivo findings. Our findings from this pilot study have the potential to serve as the basis of a larger study to further evaluate the potential impact of BOLD and MRS technology on our understanding of placental lipid and oxygen transport among women with obesity and pregestational diabetes as compared to women without these conditions. ;

Study Design

Related Conditions & MeSH terms

Placenta Diseases

Clinical Trial Details

NCT number	NCT03764878
Study type	Observational
Source	NorthShore University HealthSystem
Contact
Status	Completed
Phase
Start date	November 29, 2018
Completion date	June 1, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02577536` - PregSource: Crowdsourcing to Understand Pregnancy
Recruiting	`NCT05899101` - The Impact of Opioid and Cannabis Exposure on Fetal Growth
Completed	`NCT04168606` - Study on Retroplacental Hematomas in Finistère
Completed	`NCT05771415` - Near-infrared Spectroscopy: Differences in Placental Oxygenation in Relation to Ultrasound Maturation Grade in physiologIcal Term Pregnancies
Recruiting	`NCT03731949` - Placental Volume Analysis During Pregnanay
Not yet recruiting	`NCT06352970` - Effects of Tuberculosis Infection on Development and Function of the Placenta
Completed	`NCT05172674` - Ultrasound Diagnosis of Placental and Umbilical Cord Anomalies in Singleton Pregnancies Resulting From In-vitro Fertilization
Completed	`NCT06456645` - Effects of Smoking on Placenta and Lactation
Not yet recruiting	`NCT06314009` - Beyond MARS: Magnetic Resonance Study: A Novel Assessment of Placental Perfusion During Pregnancy
Active, not recruiting	`NCT04488861` - The START Clinic: a Feasibility Study
Not yet recruiting	`NCT05284474` - Management of Early-onset Fetal Growth Restriction: Angiogenic Factors Versus Feto-placental Doppler	N/A
Not yet recruiting	`NCT05872009` - Gestational Diabetes Mellitus: "Placental-maternal Crosstalk and Future Health"
Completed	`NCT03636698` - Effect of Chorioamnionitis on Platelet Activation and Placental Vessel Among Preterm Infants by Wnt-Flt1 Signal Pathway
Active, not recruiting	`NCT05739097` - Prospective Study on Feto-maternal outcoMe In aNemIc womEn
Completed	`NCT05245279` - Placental Perfusion in the Entire Placenta and With Sonobiopsy by Ultrasound	N/A
Completed	`NCT05644964` - The Effect of Anemia in Adolescent and Advanced Age Pregnancies
Completed	`NCT03674606` - Trial of Early Screening Test for Pre-eclampsia and Growth Restriction	Phase 4
Recruiting	`NCT04699578` - COVID-19 Infection and Fetal-neonatal Outcomes
Terminated	`NCT04525534` - Plasma Concentration of Biological Markers in Placenta Accreta Spectrum

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.